The world of microscopy is about to get a whole lot more exciting, thanks to a groundbreaking innovation that could revolutionize how we study tissues. Imagine being able to peer into the intricate architecture of a brain or a cancer biopsy without breaking the bank or sacrificing image quality. Well, that's exactly what a team led by Raju Tomer, a professor at Columbia University, has achieved with their new microscope design and lens technology. This development, published in the journal Nature Biotechnology, could be a game-changer for researchers across various fields, from neuroscience to pathology.
Breaking the Performance-Accessibility Trade-off
For years, researchers have been stuck in a dilemma when it comes to 3D tissue imaging. On one hand, oil-immersion lenses provide the sharpest images, but they're expensive, limited in depth, and require specific sample preparations. On the other hand, cheaper lenses that work at a distance through air can reach deeper into samples but produce blurry images when used with common tissue-rendering chemicals. The Tomer team's HySIL (Hybrid Solid–Liquid Optics) technology elegantly solves this conundrum.
HYSIL pairs a simple, curved solid lens with a precisely matched immersion liquid, creating a single continuous optical system. This innovation allows inexpensive air lenses to deliver high-resolution images across centimeter-scale tissues, compatible with various sample-preparation methods, and without the need for hardware changes. The team demonstrated this concept with a modular device called SCOPE, which can be added to existing light-sheet microscopes, and even developed a higher-resolution variant called Super-SCOPE.
"We've broken a long-standing trade-off in microscopy," Tomer exclaims. "By making the immersion liquid an active optical component, we achieve the resolution of expensive lab systems while maintaining the cost and footprint of equipment that fits anywhere, from teaching labs to clinics in low-resource settings."
Expanding Horizons in Tissue Analysis
The implications of this technology are far-reaching. By making 3D imaging more accessible and affordable, it opens up new possibilities for AI models in disease detection, grading, and prognosis. The team demonstrated the potential of their pLSM-SCOPE system on various samples, including whole mouse, salamander, and cavefish brains, lab-grown miniature human brain tissues, and intact human cancer biopsies.
Hanina Hibshoosh, a professor of pathology and cell biology at Columbia University, highlights the significance of 3D imaging in tissue analysis: "Examining 3D images of tissues lets you see the whole tissue architecture, not just the cross-section that pathology has traditionally been limited to. Tools like pLSM-SCOPE will become increasingly important as AI helps us analyze ever-larger amounts of tissue data."
A Collaborative Endeavor
The success of this research is a testament to the power of collaboration. The team worked with academic collaborators across life sciences and industry partner MBF Bioscience. Jack Glaser, co-founder and CEO of MBF Bioscience, emphasizes the practical impact of HySIL: "A new optical concept only changes a field if labs without specialized optics expertise can use it daily. HySIL offers the rare combination of lower cost and higher performance, making it a reliable tool for working labs across various research areas."
Looking Ahead
As Tomer reflects, the technology's ability to provide dense, tissue-scale image datasets will be transformative for biology and medicine. The future of tissue analysis looks brighter than ever, thanks to this innovative microscope technology.
